diabetes
289 projects
H2020Individual fellowship2016–2018Netherlands
BETA-BACT · Beta-cell inflammation and dysfunction induced by bacterial translocation
3 partners · 2 countries
H2020Individual fellowship2016–2018United Kingdom
AlzDiabetes · Insulin resistance and Tauopathy : Insights from Drosophila models and human brain samples
H2020Doctoral network2016–2020Netherlands
GlySign · Exploitation of Glycosylation Signatures for Precision Medicine
7 partners · 4 countries
H2020Doctoral network2016–2021Germany
REMIX · Regulation of mitochondrial expression
10 partners · 5 countries
H2020Individual fellowship2016–2018Denmark
GRO-BAT · Growth hormone: an endocrine factor that integrates thermogenic and circadian signals to regulate brown adipose tissue activity.
H2020Individual fellowship2016–2018United Kingdom
LYSOTRACK · Defining the role of lysosomal trafficking in age-associated anabolic resistance in human skeletal muscle
H2020Individual fellowship2016–2018Germany
EPOC · Understanding the molecular basis of stochastic bi-stable obesity
H2020Individual fellowship2016–2019Austria
OBEDIA-MARK · EPIGENETIC MARKERS OF DISEASE STATUS AND REVERSAL FOR PERSONALIZED MANAGEMENT OF OBESITY AND DIABETES
2 partners · 2 countries
H2020Individual fellowship2016–2018Sweden
SMILED · Skeletal Muscle Inflammation: ambivalent roles in Exercise and Diabetes
H2020Individual fellowship2016–2018Sweden
EpiHope · Epigenetic biomarkers for prediction of vascular complications and response to treatment in subjects with diabetes
H2020Individual fellowship2016–2018Spain
NANOBreg · A new therapeutic platform based on nanotechnology to promote T- and B-regulatory networks
H2020Doctoral network2016–2020Germany
ChroMe · Chromatin and Metabolism Chromatin-metabolism interactions as targets for healthy living
12 partners · 6 countries
H2020Individual fellowship2016–2018Netherlands
METAFORA · Miniaturised Metabolomics Platform for Microvascular Research
H2020Individual fellowship2016–2018Germany
GCG-T3 Dyslipidemia · Validation and Molecular Characterization of Novel Glucagon-Thyroid Hormone Conjugates for the Efficient Management of Dyslipidemia and Fatty Liver Disease
H2020Individual fellowship2016–2018France
MAIT · Evolutionary conserved T cells specific for a microbial metabolite: deciphering their development in the thymus and mapping their interactions with the gut microbiota in vivo.
H2020Individual fellowship2016–2019United Kingdom
HONEYDIAB-8 · Characterization of islet-specific CD8 T cells in the honeymoon of type 1 diabetes
H2020Individual fellowship2016–2018Italy
CKD AKI · Chronic kidney disease and acute kidney injury – evaluation of EU and global epidemiology
H2020Individual fellowship2016–2018United Kingdom
PlaEndo · The Remote Control of Maternal Metabolism by the Placenta
H2020Individual fellowship2016–2018United Kingdom
CollBioImag · Development of a cell-based system for high-throughput screening of antifibrotics
H2020Individual fellowship2016–2018United Kingdom
NUTBIO-DIAB · Nutritional biomarkers to advance understanding of association between diet and type 2 diabetes
H2020Staff exchange2016–2020Greece
MAST4HEALTH · Mastiha treatment for healthy obese with NAFLD diagnosis (MAST4HEALTH).
15 partners · 8 countries
H2020Staff exchange2016–2019France
PRETREAT · PRoteome-based assessment of vascular disease for the Establishment of a Translational REsearch plATform
5 partners · 4 countries
H2020Doctoral network2016–2020United Kingdom
EVOluTION · European Vascular Interventions and Therapeutic Innovation Network
13 partners · 6 countries
H2020Doctoral network2016–2020Austria
CaSR Biomedicine · Calcium-Sensing Receptor (CaSR): Therapeutics for Non-Communicable Diseases
18 partners · 9 countries